- Home
- NXGL vs SCNX Comparison
NXGL vs SCNX Comparison
Compare NXGL & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXGL
- SCNX
- Stock Information
- Founded
- NXGL 1997
- SCNX 2010
- Country
- NXGL United States
- SCNX United States
- Employees
- NXGL N/A
- SCNX N/A
- Industry
- NXGL Medical/Dental Instruments
- SCNX Other Pharmaceuticals
- Sector
- NXGL Health Care
- SCNX Health Care
- Exchange
- NXGL Nasdaq
- SCNX Nasdaq
- Market Cap
- NXGL 18.7M
- SCNX 21.2M
- IPO Year
- NXGL 2021
- SCNX 2020
- Fundamental
- Price
- NXGL $2.22
- SCNX $0.89
- Analyst Decision
- NXGL
- SCNX
- Analyst Count
- NXGL 0
- SCNX 0
- Target Price
- NXGL N/A
- SCNX N/A
- AVG Volume (30 Days)
- NXGL 50.3K
- SCNX 442.2K
- Earning Date
- NXGL 08-12-2025
- SCNX 11-05-2025
- Dividend Yield
- NXGL N/A
- SCNX N/A
- EPS Growth
- NXGL N/A
- SCNX N/A
- EPS
- NXGL N/A
- SCNX N/A
- Revenue
- NXGL $11,672,000.00
- SCNX $128,202.00
- Revenue This Year
- NXGL $46.60
- SCNX N/A
- Revenue Next Year
- NXGL $47.96
- SCNX N/A
- P/E Ratio
- NXGL N/A
- SCNX N/A
- Revenue Growth
- NXGL 133.02
- SCNX N/A
- 52 Week Low
- NXGL $2.10
- SCNX $0.69
- 52 Week High
- NXGL $5.10
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- NXGL 41.78
- SCNX 26.77
- Support Level
- NXGL $2.18
- SCNX $0.93
- Resistance Level
- NXGL $2.59
- SCNX $0.98
- Average True Range (ATR)
- NXGL 0.15
- SCNX 0.10
- MACD
- NXGL -0.01
- SCNX -0.02
- Stochastic Oscillator
- NXGL 9.76
- SCNX 17.53
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.